NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/08/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization835.48 mln
Float33.90 mln
Earnings Date05/08/2026
EPS
2.03
Solid
P / E
9.36
Undervalued
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.58
Likely reliable
1-Year Forecast
26.86
Exceptional upside
Relative Strength
9
/ 100
Severely lagging
Business Description
Amphastar Pharmaceuticals is a drug maker based in Rancho Cucamonga, California, operating across the United States, China, and France since 1996. The company produces and sells a broad range of injectable, inhaled, and nasal medicines, covering both branded and generic treatments for conditions such as severe low blood sugar, asthma, opioid overdose, blood clots, and osteoporosis, among others. Amphastar also supplies raw pharmaceutical ingredients, including insulin, to support broader drug manufacturing needs.